UBS Group’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Sell |
|
|||||
|
2025
Q1 | $48.2K | Buy |
|
|||||
|
2024
Q4 | $100K | Buy |
|
|||||
|
2024
Q3 | $135K | Buy |
|
|||||
|
2024
Q2 | $70.3K | Sell |
|
|||||
|
2024
Q1 | $367K | Buy |
|
|||||
|
2023
Q4 | $197K | Buy |
|
|||||
|
2023
Q3 | $79.5K | Sell |
|
|||||
|
2023
Q2 | $120K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $2.98K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1K | Sell |
|
|||||
|
2022
Q1 | $26K | Sell |
|
|||||
|
2021
Q4 | $49K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1K | Sell |
|
|||||
|
2021
Q1 | $20K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $14K | Buy |
|